Glutaminolysis gets the spotlight in cancer

Detalles Bibliográficos
Autor principal: Herranz, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
News
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355212/
https://www.ncbi.nlm.nih.gov/pubmed/28053289
http://dx.doi.org/10.18632/oncotarget.14384
_version_ 1782515499290066944
author Herranz, Daniel
author_facet Herranz, Daniel
author_sort Herranz, Daniel
collection PubMed
description
format Online
Article
Text
id pubmed-5355212
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-53552122017-04-26 Glutaminolysis gets the spotlight in cancer Herranz, Daniel Oncotarget News Impact Journals LLC 2016-12-30 /pmc/articles/PMC5355212/ /pubmed/28053289 http://dx.doi.org/10.18632/oncotarget.14384 Text en Copyright: © 2017 Herranz http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle News
Herranz, Daniel
Glutaminolysis gets the spotlight in cancer
title Glutaminolysis gets the spotlight in cancer
title_full Glutaminolysis gets the spotlight in cancer
title_fullStr Glutaminolysis gets the spotlight in cancer
title_full_unstemmed Glutaminolysis gets the spotlight in cancer
title_short Glutaminolysis gets the spotlight in cancer
title_sort glutaminolysis gets the spotlight in cancer
topic News
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355212/
https://www.ncbi.nlm.nih.gov/pubmed/28053289
http://dx.doi.org/10.18632/oncotarget.14384
work_keys_str_mv AT herranzdaniel glutaminolysisgetsthespotlightincancer

Ejemplares similares